Cost-Utility of Fingolimod Compared With Dimethyl Fumarate (Dmf) In Highly Active Relapsing Remitting Multiple Sclerosis (Rrms) In England- Comparison of A Markov and Discrete Event Simulation Model
Nov 1, 2015, 00:00
10.1016/j.jval.2015.09.2476
https://www.valueinhealthjournal.com/article/S1098-3015(15)04552-0/fulltext
Title :
Cost-Utility of Fingolimod Compared With Dimethyl Fumarate (Dmf) In Highly Active Relapsing Remitting Multiple Sclerosis (Rrms) In England- Comparison of A Markov and Discrete Event Simulation Model
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(15)04552-0&doi=10.1016/j.jval.2015.09.2476
First page :
A759
Section Title :
Research Podium Presentations - Session 1 and Session 2
Open access? :
No
Section Order :
2353